DURECT Corporation
NASDAQ:DRRX
Overview | Financials
Company Name | DURECT Corporation |
Symbol | DRRX |
Currency | USD |
Price | 1.33 |
Market Cap | 41,282,402 |
Dividend Yield | 0% |
52-week-range | 0.47 - 1.88 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. James E. Brown D.V.M. |
Website | https://www.durect.com |
An error occurred while fetching data.
About DURECT Corporation
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD